pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiske midler - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
isofluran baxter -
baxter medical ab - isofluran - væske til inhalasjonsdamp
metronidazol baxter viaflo 5 mg/ ml
baxter medical ab - metronidazol - infusjonsvæske, oppløsning - 5 mg/ ml
bleomycin baxter 15000 ie
baxter medical ab - bleomycinsulfat - pulver til injeksjons-/infusjonsvæske, oppløsning - 15000 ie
glucos baxter viaflo 50 mg/ ml
baxter medical ab - glukosemonohydrat - infusjonsvæske, oppløsning - 50 mg/ ml
mannitol baxter viaflo 150 mg/ ml
baxter medical ab - mannitol - infusjonsvæske, oppløsning - 150 mg/ ml
natriumklorid baxter 9 mg/ ml
baxter medical ab - natriumklorid - infusjonsvæske, oppløsning - 9 mg/ ml
natriumklorid baxter 9 mg/ ml
baxter medical ab - natriumklorid - infusjonsvæske, oppløsning - 9 mg/ ml
natriumklorid baxter viaflo 9 mg/ ml
baxter medical ab - natriumklorid - infusjonsvæske, oppløsning - 9 mg/ ml
natriumklorid-glucos baxter viaflo 4.5 mg/ ml / 25 mg/ ml
baxter medical ab - natriumklorid / glukosemonohydrat - infusjonsvæske, oppløsning - 4.5 mg/ ml / 25 mg/ ml